Klivira
Request demo

Optimizing Tresiba Prior Authorization Workflows in Gastroenterology

While Tresiba (insulin degludec) is primarily managed by endocrinologists or primary care, gastroenterology practices often encounter prior authorization requirements for patients with co-morbid diabetes. Klivira streamlines Tresiba prior authorization for your GI patient population.

Managing prior authorizations for medications not directly related to a specialty's primary focus, such as Tresiba for diabetes patients within a gastroenterology practice, adds complexity. This necessitates robust systems to handle diverse PA requirements, ensuring continuity of care for patients with multiple chronic conditions. Klivira provides the automation and connectivity to manage these varied PA needs efficiently.

The Administrative Intersection: Tresiba and Gastroenterology Patients

Tresiba, a long-acting insulin, is a critical medication for patients with diabetes. While not a primary therapeutic agent within gastroenterology, GI practices frequently care for patients with co-morbid diabetes who require ongoing insulin therapy. Managing prior authorizations for these non-GI specific medications, particularly those under the pharmacy benefit, presents an administrative challenge that can impact patient care continuity and practice efficiency.

Key Documentation for Tresiba Prior Authorization

  • Confirmed diagnosis of Type 1 or Type 2 diabetes mellitus.
  • Documentation of A1c levels and blood glucose monitoring data.
  • History of prior anti-diabetic therapies, including adherence and response.
  • Clinical rationale for Tresiba over alternative insulins, if applicable.
  • Absence of contraindications or clinically significant drug interactions.

Common PA Challenges for Insulins within a GI Workflow

Gastroenterology practices, focused on conditions like IBD and hepatitis, may face unique hurdles when processing prior authorizations for medications like Tresiba. These include navigating payer-specific step therapy protocols for insulins, ensuring complete documentation for a condition not primarily managed by the GI team, and coordinating information flow with other specialists involved in the patient's diabetes care. Such complexities can lead to delays or denials if not managed with precision.

Navigating Pharmacy Benefit Prior Authorizations for Tresiba

Tresiba is typically covered under the pharmacy benefit, requiring electronic prior authorization (ePA) submissions via NCPDP SCRIPT standards. This differs from medical benefit PAs common for provider-administered biologics in GI. Klivira's platform provides comprehensive support for both medical and pharmacy benefit PAs, ensuring that all medication authorizations, regardless of benefit type, are managed through a unified, automated process.

Klivira's Solution for Tresiba PA in Gastroenterology

  • Automated data extraction from EMRs for Tresiba prescription details and patient history.
  • Intelligent routing of ePA requests via NCPDP SCRIPT to appropriate payers.
  • Real-time status tracking and notification for all Tresiba prior authorization submissions.
  • Policy library integration to identify payer-specific requirements and step therapy for insulins.
  • Workflow automation that reduces manual data entry and administrative burden for GI staff.

Ensuring Continuity of Care for GI Patients with Diabetes

By automating the prior authorization process for medications like Tresiba, Klivira empowers gastroenterology practices to maintain focus on their core specialty while ensuring that patients with co-morbid conditions receive timely access to all necessary treatments. This integrated approach minimizes administrative overhead, reduces the risk of PA-related treatment delays, and supports a more holistic patient management strategy across complex care pathways.

Frequently asked questions

How does Klivira integrate with our EMR to pull Tresiba prescription details?

Klivira leverages SMART on FHIR and other integration methods to securely connect with your EMR system. This allows for automated extraction of patient demographics, diagnosis codes, medication history, and lab results relevant for Tresiba prior authorization forms, minimizing manual data entry.

Can Klivira handle the specific step therapy requirements for Tresiba?

Yes, Klivira's platform incorporates a comprehensive policy library that includes payer-specific step therapy requirements for various drug classes, including insulins. Our system guides your team through the necessary steps and documentation to ensure compliance with payer policies for Tresiba.

Is Tresiba prior authorization typically processed under medical or pharmacy benefit?

Tresiba, as a self-administered injectable medication, is almost always processed under the patient's pharmacy benefit. Klivira's platform supports electronic prior authorization (ePA) submissions using NCPDP SCRIPT standards, specifically designed for pharmacy benefit medications.

What if the patient's endocrinologist is the primary prescriber for Tresiba?

Klivira's system facilitates coordination of care by centralizing PA management. Even if the endocrinologist is the primary prescriber, your gastroenterology practice can use Klivira to manage the administrative aspects of the Tresiba PA, ensuring all relevant clinical data is accessible for submission and tracking.

How does Klivira help reduce denial rates for Tresiba PAs in a GI practice?

By automating documentation checks, aligning submissions with payer-specific guidelines, and providing real-time status updates, Klivira significantly reduces common denial reasons such as incomplete documentation or missed step therapy. This proactive approach ensures higher first-pass approval rates for Tresiba.

Related coverage

Other tresiba prior authorization by payer

Other tresiba prior authorization by specialty

Ready to automate prior auth for this drug?

See how Klivira automates prior authorizations for your team.

Request a demo